Lindbrook Capital »

4d Molecular Therapeutics In shares owned by Lindbrook Capital

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1k 98 10.81
2024-06-30 $1.4k 68 20.99
2024-03-31 $2.2k 68 31.85
2023-12-31 $1.4k 68 20.26